Bridgewater Associates’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Sell
4,963
-78,607
-94% -$4.77M ﹤0.01% 957
2026
Q1
$4.09M Buy
+83,570
New +$3.9M 0.02% 469
2022
Q4
– Sell
-69,130
Closed -$2.87M – 841
2022
Q3
$2.87M Buy
69,130
+31,769
+85% +$1.44M 0.01% 486
2022
Q2
$1.59M Sell
37,361
-61,587
-62% -$3.45M 0.01% 726
2022
Q1
$7.63M Buy
+98,948
New +$6.77M 0.03% 360
2021
Q3
– Sell
-58,579
Closed -$4.92M – 702
2021
Q2
$4.92M Buy
+58,579
New +$4.74M 0.03% 333
2021
Q1
– Sell
-21,474
Closed -$1.72M – 482
2020
Q4
$1.72M Buy
21,474
+5,118
+31% +$372K 0.01% 325
2020
Q3
$1.06M Buy
16,356
+12,443
+318% +$804K 0.01% 334
2020
Q2
$234K Buy
+3,913
New +$212K ﹤0.01% 359
2020
Q1
– Sell
-8,815
Closed -$494K – 448
2019
Q4
$494K Buy
+8,815
New +$456K 0.01% 414

Other funds holding CGNX

Bridgewater Associates's CGNX Position: Q2 2026 in Review

Bridgewater Associates reduced its Cognex (CGNX) stake by 94% in Q2 2026, selling an estimated $4.77M and leaving 4,963 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Bridgewater Associates first reported a position in CGNX in Q4 2019 and has held it in 10 quarters since. The position peaked at $7.63M in Q1 2022. 654 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Bridgewater Associates held 4,963 shares of Cognex worth $359K as of Q2 2026.
  • Bridgewater Associates sold 78,607 Cognex shares in Q2 2026, an estimated $4.77M.
  • Cognex made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #957 holding.
  • Bridgewater Associates first reported a position in Cognex in Q4 2019 and has held it in 10 quarters since.
  • Bridgewater Associates's Cognex position peaked at $7.63M in Q1 2022.
  • 654 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.